Thanh bên bài viết

PDF
Số lượt xem tóm tắt: 0
Số lượt xem PDF: 0
DOI: 10.60137/tmhvn.v70i74.246
Số xuất bản
Tập 70 Số 74 (2025): Số tiếng Anh
Chuyên mục
Các bài báo
Trích dẫn bài báo
Lê, T. M. H., Phan, T. H., Phạm, V. H., Nguyễn, T. T. T., Hoàng, N. P., Nguyễn, D. K., Nguyễn, B. H., Phạm, T. H., & Phùng, T. H. OVERVIEW OF CHARACTERISTICS OF ADHERENCE TO TREATMENT OF ALLERGIC RHINITIS. Tạp chí Tai Mũi Họng Việt Nam, 70(74). https://doi.org/10.60137/tmhvn.v70i74.246

OVERVIEW OF CHARACTERISTICS OF ADHERENCE TO TREATMENT OF ALLERGIC RHINITIS

Lê Tự Minh Hoàng, Phan Thị Hoài , Phạm Văn Hiệp1, Nguyễn Thị Thanh Trà, Hoàng Ngọc Phương , Nguyễn Du Khánh , Nguyễn Bích Hường, Phạm Thị Hằng , Phùng Thị Hòa2,
1 BỆNH VIỆN TAI MŨI HỌNG TRUNG ƯƠNG
2 University of Medicine and Pharmacy, Vietnam National University, Hanoi

Nội dung chính của bài viết

Tóm tắt

ABSTRACT

Objective: Overview of characteristics of treatment adherence in Allergic Rhinitis. Methods: A scoping review. Results: Of the 51 relevant articles, 5 articles that met the selection criteria were included in the study. These studies were conducted in many different countries, all showing the complex characteristics of adherence to treatment of allergic rhinitis in real-life contexts, thereby providing initial suggestions for more effective, patient-centered intervention strategies to improve clinical outcomes and quality of life for patients. Conclusion: Treatment adherence in allergic rhinitis patients is not a single issue of willpower, but a multifactorial challenge, reflecting the complexity of the disease and human behavior in real-life settings

Từ khóa

Treatment adherence, Allergic rhinitis

Chi tiết bài viết

Tài liệu tham khảo

1. Garrido-Fernández, S., et al., Satisfaction, Qol and adherence of patients allergic to dust mites and/or pollens undergoing sublingual immunotherapy. Immunotherapy, 2024. 16(10): p. 693-704.
2. Sousa‐Pinto, B., et al., Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study. Clinical & Experimental Allergy, 2025. 55(3): p. 226-238.
3. Zhang, J., et al., Efficacy and safety of intratonsillar immunotherapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial. Annals of Allergy, Asthma & Immunology, 2024. 132(3): p. 346-354. e1.
4. Endaryanto, A. and R.A. Nugraha, Safety profile and issues of subcutaneous immunotherapy in the treatment of children with allergic rhinitis. Cells, 2022. 11(9): p. 1584.
5. Phinyo, P., et al., As-needed versus regular intranasal corticosteroid for allergic rhinitis: A systematic review and meta-analysis. Asian Pacific Journal of Allergy and Immunology, 2022. 40(3): p. 195-204.